Innocutis Introduces Dexter the Dystrophic Nail to Educate Patients

Innocutis launched an animated social media campaign to educate on the prevalence of nail dystrophy and Nuvail as a viable treatment option. The antagonist of healthy nails in what the company calls a “fun, light-hearted, social media campaign” is Dexter, the dystrophic nail. Dexter epitomizes nail dystrophy by representing the splitting, fragile, and weak nail associated with dystrophic nails that many patients experience. The company says it hopes to educate the general public on the various forms of nail dystrophy; most commonly being mycotic, psoriatic, and brittle nail syndrome (affecting as much as 20 percent of US population). 

Nuvail addresses the signs and symptoms of nail dystrophy by protecting and fortifying the nail plate. Nuvail is formulated to mechanically support the damaged nail plate using a proprietary polymer blend that creates a strong adhesion to the nail surface. Nuvail's patented polymer creates a breathable barrier allowing for oxygen transfer to the germinal matrix while blocking water absorption; therefore, preventing the wet-dry cycle that commonly leads to damaged nails. 

Daily application of Nuvail also protects the nail from harm caused by work activity such as direct abrasion, friction and over exposure to water or chemicals.

To learn more, visit http://nuvail-rx.com/weak-brittle-nails/

Or, direct patients to follow Dexter on Twitter (https://twitter.com/dystrophicnail) or like Dexter on Facebook (https://www.facebook.com/DexterTheDystrophicNail)